Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.hipert.2020.05.005 http://scihub22266oqcxt.onion/10.1016/j.hipert.2020.05.005 32527699!7250776!32527699     free     free     free       Hipertens+Riesgo+Vasc 2020 ; 37 (4): 169-175 Nephropedia Template TP {{tp|p=32527699|t=2020. El SRAA y el SARS-CoV-2: el acertijo a resolver |pdf=|usr=}}{{32527699}} gab.com Text El SRAA y el SARS-CoV-2: el acertijo a resolver JO: Hipertens Riesgo Vasc http://www.kidney.de/pget.php?&tw=1&pmid=32527699 #FOAvip The first case of COVID-19 was reported on 31 December 2019 in Wuhan, China. Ever since there has been unprecedented and growing interest in learning about all aspects of this new disease. Debate has been generated as to the association between antihypertensive therapy with renin-angiotensin-aldosterone system (RAAS) inhibitors and SARS-CoV-2 infection. While many questions as yet remain unanswered, the aim of this report is to inform health professionals about the current state of knowledge. Because this is an ever-evolving topic, the recommendation is that it be updated as new evidence becomes available. Below, we provide a review of pre-clinical and clinical studies that link coronavirus to the RAAS. Twit Text FOAVip El SRAA y el SARS-CoV-2: el acertijo a resolver ????Hipertens Riesgo Vasc http://www.kidney.de/pget.php?&tw=1&pmid=32527699 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32527699 #FOAvip English Wikipedia <ref>{{Cite pmid|32527699}}</ref> El SRAA y el SARS-CoV-2: el acertijo a resolver #MMPMID32527699 Choi M; Aiello EA; Ennis IL; Villa-Abrille MC Hipertens Riesgo Vasc 2020[Oct]; 37 (4): 169-175 PMID32527699show ga The first case of COVID-19 was reported on 31 December 2019 in Wuhan, China. Ever since there has been unprecedented and growing interest in learning about all aspects of this new disease. Debate has been generated as to the association between antihypertensive therapy with renin-angiotensin-aldosterone system (RAAS) inhibitors and SARS-CoV-2 infection. While many questions as yet remain unanswered, the aim of this report is to inform health professionals about the current state of knowledge. Because this is an ever-evolving topic, the recommendation is that it be updated as new evidence becomes available. Below, we provide a review of pre-clinical and clinical studies that link coronavirus to the RAAS. |*Betacoronavirus[MESH] |*Pandemics/prevention & control[MESH] |ADAM17 Protein/physiology[MESH] |Angiotensin II/physiology[MESH] |Angiotensin Receptor Antagonists/adverse effects/pharmacology/therapeutic use[MESH] |Angiotensin-Converting Enzyme 2[MESH] |Angiotensin-Converting Enzyme Inhibitors/adverse effects/pharmacology/therapeutic use[MESH] |Antihypertensive Agents/adverse effects/pharmacology/therapeutic use[MESH] |COVID-19[MESH] |COVID-19 Vaccines[MESH] |Coronavirus Infections/complications/immunology/*physiopathology/prevention & control[MESH] |Humans[MESH] |Hypertension/complications/physiopathology[MESH] |Lung/physiopathology[MESH] |Models, Biological[MESH] |Peptidyl-Dipeptidase A/drug effects/physiology[MESH] |Pneumonia, Viral/complications/immunology/*physiopathology/prevention & control[MESH] |Receptors, Virus/drug effects[MESH] |Renin-Angiotensin System/drug effects/*physiology[MESH] |Respiratory Distress Syndrome/etiology/physiopathology[MESH] |SARS-CoV-2[MESH] |Serine Endopeptidases/physiology[MESH] |Viral Vaccines[MESH]El SRAA y el SARS-CoV-2: el acertijo a resolver (epmc).pdf DeepDyve Pubget Overpricing